Related Experiment Video

Updated: Jul 14, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Statins and peripheral arterial disease: effects on claudication, disease progression, and prevention of

Giuseppe Coppola1, Salvatore Novo

  • 1Department of Internal Medicine, Cardiovascular and Nephro-Urological Diseases, University of Palermo, Chair of Cardiovascular Disease, Palermo, Italy. g.coppola@unipa.it

Archives of Medical Research
|June 15, 2007
PubMed

Insights

Peripheral arterial disease (PAD) patients face high cardiovascular risks. Best medical treatment, including statins and ACE-inhibitors, is crucial for improving outcomes and preventing events.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Surgery
  • Pharmacology

Background:

  • Peripheral arterial disease (PAD) is a significant manifestation of atherosclerosis, comparable to coronary heart disease (CHD) and cerebrovascular disease (CVD).
  • Patients with PAD represent a high-risk group for fatal and non-fatal cardiovascular and cerebrovascular events.
  • Optimal medical management is essential, improving the safety and durability of interventions for PAD.

Purpose of the Study:

  • To highlight the critical role of best medical treatment in managing PAD patients.
  • To emphasize the dual benefit of statins in reducing vascular events and improving PAD symptoms.
  • To underscore the importance of addressing the overall high cardiovascular risk in PAD patients.

Main Methods:

  • Review of recent studies on pharmacological interventions for PAD.
  • Analysis of the impact of ACE-inhibitors (e.g., ramipril), statins, and antiplatelet drugs.
  • Consideration of pleiotropic effects of statins on hemostasis, vasculature, and inflammation.

Main Results:

  • ACE-inhibitors, statins, and antiplatelet drugs have shown promise in reducing cardiovascular morbidity and mortality in PAD.
  • Statins not only mitigate vascular event risk but also improve PAD-related symptoms like intermittent claudication.
  • Statins demonstrate beneficial pleiotropic effects and may improve renal function, a recognized vascular risk factor.

Conclusions:

  • Comprehensive medical treatment is paramount for PAD patients, focusing on both local symptoms and systemic cardiovascular risk reduction.
  • Statins offer significant benefits beyond lipid-lowering, impacting vascular health and potentially renal function.
  • Aggressive management of cardiovascular risk factors is essential for improving outcomes in patients with lower limb PAD.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...